The Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Japanese Patients after Allogeneic Stem Cell Transplantation

Patients who have undergone hematopoietic stem cell transplantation (HSCT) for hematological disease experience high mortality when infected by coronavirus disease 2019 (COVID-19). However, the safety and efficacy of the COVID-19 vaccine in HSCT patients remain to be investigated. We prospectively e...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Marika, Yakushijin, Kimikazu, Funakoshi, Yohei, Ohji, Goh, Hojo, Wataru, Sakai, Hironori, Saeki, Miki, Hirakawa, Yuri, Matsumoto, Sakuya, Sakai, Rina, Nagao, Shigeki, Kitao, Akihito, Miyata, Yoshiharu, Koyama, Taiji, Saito, Yasuyuki, Kawamoto, Shinichiro, Ito, Mitsuhiro, Murayama, Tohru, Matsuoka, Hiroshi, Minami, Hironobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874528/
https://www.ncbi.nlm.nih.gov/pubmed/35214617
http://dx.doi.org/10.3390/vaccines10020158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874528/
https://www.ncbi.nlm.nih.gov/pubmed/35214617
http://dx.doi.org/10.3390/vaccines10020158

Ejemplares similares